Why Pharma Leaders Are Rethinking Training ROI at Connect 2026

Pharmaceutical companies have spent years treating learning management as a compliance checkbox rather than a growth lever. That mindset is shifting fast, and it's exactly the conversation MapleLMS is bringing to Connect 2026, its executive lounge experience during Dreamforce26 in San Francisco.

On Day 1, Session 2, "Driving Revenue Growth in Pharma with AI-LMS and Salesforce" (1:30 PM - 1:50 PM) tackles a question more life sciences leaders are asking: what happens when training data lives inside the same CRM that tracks pipeline, territory performance, and rep readiness? When an AI-powered LMS is natively integrated with Salesforce, learning stops being a side system and becomes a revenue signal. Sales enablement teams can see which reps are certified on new drug indications before a call is even booked. Medical Science Liaisons can be matched to accounts based on training completion and specialty depth, not just availability.

 

This session will unpack real frameworks for connecting learning completion rates to quota attainment, faster onboarding for new field reps, and shorter ramp times for product launches, all without leaving the Salesforce environment sales teams already trust.

 

If you're in pharma, medtech, or life sciences and want to see how AI-LMS and Salesforce work together to move revenue, not just checkboxes, this is the session to catch.

 

What is Connect 2026?


It's MapleLMS's dedicated lounge and session series running alongside Dreamforce26, September 15–17, 2026, in San Francisco, built for exactly these kinds of conversations. Reserve your seat and meet MapleLMS during Dreamforce26; spots for Connect 2026 sessions are limited.

Comments

Popular posts from this blog

What LMS Platforms Offer Customizable Dashboards for Sales Teams?

Why is a Modern Learning Management System Essential Today?

Top 5 Corporate Learning Management Systems (LMS) in the USA 2023.